Meeting
2018 Gastrointestinal Cancers Symposium
Mice with targeted KrasG12D and loss of p53 in the liver: A robust model for studying immunologic interventions for treating cholangiocarcinoma
Authors
Booyeon Julia Han
University of Rochester Medical Center, Rochester, NY
Booyeon Julia Han , Nathania Figueroa , Brian Belt , Michael O'Dell , Aram F. Hezel , David Linehan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 281)
DOI
10.1200/JCO.2018.36.4_suppl.281
Abstract #
281
Poster Bd #
D14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Updated molecular analysis of MET exon 14 skipping mutations (METex14) in non-small cell lung cancer (NSCLC).
First Author: Jennifer Aline Marks
Poster
2023 ASCO Annual Meeting
Immune landscape of patients with metastatic non-clear cell renal cell carcinoma (nccRCC) treated with atezolizumab plus bevacizumab.
First Author: Renee Maria Saliby
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development.
First Author: Wan Ying Tan
Poster
2022 ASCO Annual Meeting
Genomic characterization and translational immunotherapy of microsatellite instability-high (MSI-H) in cholangiocarcinoma.
First Author: Xu Yang